Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

Recruiting now · Phase 2

Conditions studied: Burns

In brief

To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.

Key facts

Study ID
NCT01297400
Run by
Skingenix, Inc.
People needed
60
Starts
2022-03-11
Expected to finish
2026-12-31
Last updated by the study team
2026-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.